Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Tetsuya FUJIKAWA"'
Autor:
Yusuke Kobayashi, Tetsuya Fujikawa, Aiko Haruna, Rina Kawano, Moe Ozawa, Tatsuya Haze, Shiro Komiya, Shota Suzuki, Yuki Ohki, Akira Fujiwara, Sanae Saka, Nobuhito Hirawa, Yoshiyuki Toya, Kouichi Tamura
Publikováno v:
Medicina, Vol 60, Iss 1, p 75 (2023)
Background and Objectives: Omega-3 fatty acids have potent lipid-lowering and antiplatelet effects; however, randomized controlled trials have yet to examine the effect of high-dose omega-3 fatty acid administration on peripheral artery disease (PAD)
Externí odkaz:
https://doaj.org/article/c00fb07937574047aaf7e05e246e5b8e
Autor:
Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Sho Kinguchi, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 1, Pp 118-125 (2021)
Our previous randomized controlled trial comparing the total dose of weekly versus biweekly continuous erythropoietin receptor activator (CERA) therapy to maintain optimal hemoglobin (Hb) levels showed no significant differences between the two thera
Externí odkaz:
https://doaj.org/article/bc8b5ab08cbb441db2084058f0dfc4de
Autor:
Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 4, Pp 870-878 (2021)
Abstract Although continuous erythropoietin receptor activators (CERAs) are widely used erythropoiesis‐stimulating agents for correcting renal anemia in patients undergoing hemodialysis (HD), few reports have examined weekly CERA administration. In
Externí odkaz:
https://doaj.org/article/62f0e25c3ca842bebc112335d5734937
Autor:
Kohji Ohki, Hiromichi Wakui, Kazushi Uneda, Kengo Azushima, Kotaro Haruhara, Sho Kinguchi, Shingo Urate, Takayuki Yamada, Takahiro Yamaji, Ryu Kobayashi, Tomohiko Kanaoka, Shintaro Minegishi, Tomoaki Ishigami, Tetsuya Fujikawa, Yoshiyuki Toya, Kouichi Tamura
Publikováno v:
Kidney Diseases, Vol 6, Iss 4, Pp 299-308 (2020)
Introduction: Erythropoietin-stimulating agents (ESAs) are used to treat renal anemia in patients with non-dialysis CKD, but this can lead to increases in blood pressure (BP). Objective: We investigated the effects of continuous erythropoietin recept
Externí odkaz:
https://doaj.org/article/5cabaa8899da467ca1696452109a817c
Autor:
Hiromichi Wakui, Takahiro Yamaji, Kengo Azushima, Kazushi Uneda, Kotaro Haruhara, Akiko Nakamura, Kohji Ohki, Sho Kinguchi, Ryu Kobayashi, Shingo Urate, Toru Suzuki, Daisuke Kamimura, Shintaro Minegishi, Tomoaki Ishigami, Tomohiko Kanaoka, Kohei Matsuo, Tomoyuki Miyazaki, Tetsuya Fujikawa, Akio Yamashita, Kouichi Tamura
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Abstract Chronic kidney disease (CKD) progresses to end-stage renal failure via renal tubulointerstitial fibrosis. Malnutrition, inflammation, and arteriosclerosis interact to exacerbate the poor prognosis of CKD, and their effective management is th
Externí odkaz:
https://doaj.org/article/bfec8e8a9b8a42ca8255a052c924dad8
Autor:
Yusuke Kobayashi, Hiroaki Ishiguro, Tetsuya Fujikawa, Hideo Kobayashi, Koichiro Sumida, Minako Kagimoto, Yuki Okuyama, Yosuke Ehara, Mari Katsumata, Megumi Fujita, Akira Fujiwara, Sanae Saka, Keisuke Yatsu, Nobuhito Hirawa, Yoshiyuki Toya, Gen Yasuda, Satoshi Umemura, Kouichi Tamura
Publikováno v:
Clinical and Experimental Hypertension, Vol 41, Iss 2, Pp 194-201 (2019)
Background: The carotid bulb has a high density of baroreceptors that play an important role in maintaining blood pressure. We hypothesized that atherosclerosis of the carotid bulb would reflect the severity of orthostatic hypotension more accurately
Externí odkaz:
https://doaj.org/article/4eb2e6a0a77e494e8ff9eaa0e45054b4
Autor:
Kengo Azushima, Hiromichi Wakui, Kazushi Uneda, Sona Haku, Ryu Kobayashi, Kohji Ohki, Sho Kinguchi, Kotaro Haruhara, Tetsuya Fujikawa, Yoshiyuki Toya, Satoshi Umemura, Kouichi Tamura
Publikováno v:
Clinical and Experimental Hypertension, Vol 39, Iss 7, Pp 665-671 (2017)
As there may be an association between within-visit blood pressure (BP) variability and cardiovascular disease (CVD), we investigated the clinical significance of this BP variability in non-dialysis chronic kidney disease (CKD) patients. Materials an
Externí odkaz:
https://doaj.org/article/30f4f037207846dcb7422e846de391fb
Autor:
Tomoyuki Kawano, Tadashi Kuji, Tetsuya Fujikawa, Eiko Ueda, Midori Shino, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura, Nobuhito Hirawa, Yoshiyuki Toya
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-7 (2017)
Abstract Background We recently demonstrated, using an index of recently synthesized hemoglobin, reticulocyte hemoglobin (Ret-Hb), that iron administration remarkably improves hemoglobin (Hb) synthesis during the period of high activation of erythrop
Externí odkaz:
https://doaj.org/article/cd4d21e118bb473fb4ed37f0a4b7bf8b
Autor:
Sho Kinguchi, Hiromichi Wakui, Kengo Azushima, Kotaro Haruhara, Tomoyuki Koguchi, Kohji Ohki, Kazushi Uneda, Miyuki Matsuda, Sona Haku, Takahiro Yamaji, Takayuki Yamada, Ryu Kobayashi, Shintaro Minegishi, Tomoaki Ishigami, Akio Yamashita, Tetsuya Fujikawa, Kouichi Tamura
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 8 (2019)
Background We have previously shown that ATRAP (angiotensin II receptor–associated protein; Agtrap) interacts with AT1R (angiotensin II type 1 receptor) and promotes constitutive internalization of AT1R so as to inhibit hyperactivation of its downs
Externí odkaz:
https://doaj.org/article/140fbee763e948339f481154a0cff135
Autor:
Kengo Azushima, Kouichi Tamura, Hiromichi Wakui, Akinobu Maeda, Masato Ohsawa, Kazushi Uneda, Ryu Kobayashi, Tomohiko Kanaoka, Toru Dejima, Tetsuya Fujikawa, Akio Yamashita, Yoshiyuki Toya, Satoshi Umemura
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e75560 (2013)
Accumulating evidence indicates that metabolic dysfunction with visceral obesity is a major medical problem associated with the development of hypertension, type 2 diabetes (T2DM) and dyslipidemia, and ultimately severe cardiovascular and renal disea
Externí odkaz:
https://doaj.org/article/63de90aab9204d4da705966c4f80c257